Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

7 Dec 2017 07:00

RNS Number : 6235Y
S & U PLC
07 December 2017
Β 

7th December 2017

Β 

Β 

S&U plc

("S&U"or "the Group")

Β 

Β 

TRADING STATEMENT

Β 

S&U plc, the specialist hire purchase motor finance and property bridging lender, announces its trading update for the period from 1st August to 6th December 2017 and is pleased to continue trading in line with expectations.

Β 

Motor Finance

Advantage Finance, our specialist motor finance provider based in Grimsby continues its excellent progress. Despite recent downgraded forecasts for the UK economy, Advantage applications for finance have been very good. This has enabled Advantage both to maintain this year's rate of transactions growth and to revise, refine and further strengthen its under-writing model.

Β 

As a result, live customer numbers have grown to 53,000 from 49,000 at the half year; this means that net customer receivables now stand at over Β£240m for the first time, compared to nearly Β£227m in July.

Β 

Monthly collections and overall credit quality remain good. Whilst rolling 12 months impairment to revenue has increased slightly to 23.4%, this continues to be primarily due to overall portfolio product mix.

Β 

Whilst the above underwriting refinements have seen a slight reduction in loan approvals, appropriate in a more uncertain economic climate, the introduction of Advantage's new e-signature Dealfo system has been well received by both customers and brokers and has led to an improvement in the approval-transaction rate.

Β 

Property Bridging Finance

Our pilot bridging operation, Aspen Finance, has made significant progress and increased its loan book to Β£9m from Β£2m in July. Margins and LTV are within budget and very early repayment experience is good.

Β 

Aspen's growing reputation for efficient, consistent and prompt service to the broking community, augers well for a successful trial period concluding in H2 2018.

Β 

Funding

Having obtained further funding of Β£20m during the period, the Group now has total available committed facilities of Β£115m, sufficient to accommodate current growth at both Advantage and Aspen. Further facilities will be arranged as required.

Β 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said:

Β 

"WhateverΒ the current political uncertainty, particularly over Brexit, and despite a forecast slowing economy, demand for S&U's products remains very robust. Our selective lending and continuous refinement of our under-writing underpin our debt quality and produce steady sustainable growth.

Β 

"I am pleased to see this seemingly becoming more widely recognised within the investing community; we will continue our high standards of responsible lending and the excellent performance which results from this."

Β 

For further information, please contact:

Β 

S&U plc:Β www.suplc.co.ukΒ 

Anthony Coombs, Chairman 0121 705 7777

Β 

Peel Hunt

Adrian Trimmings/Rishi Shah 020 7418 8900

Β 

Media and Investor Relations

Ged Brumby 020 3047 2527

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBIBDDRBGBGRL
Date   Source Headline
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.